Viatris Inc. VTRS
17.83
0.41
2.35%
as of 25 Sep
- Market cap
- $20.0B
- P/E
- 0.0×
Follow VTRS
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Viatris Inc. (VTRS) Book value per share
Viatris Inc.'s book value per share at the end of fiscal 2025 was 12.6×, down 19.5% from 15.6× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 12.3×. Over the past ten years it has ranged from 12.6× (fiscal 2025) to 38.2× (fiscal 2020) — the current reading is the lowest in ten years. Viatris Inc. ranks 16th of 86 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Annual
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 12.6× | (19.53%) |
| FY2024 | 15.6× | (8.42%) |
| FY2023 | 17.1× | (1.92%) |
| FY2022 | 17.4× | 2.55% |
| FY2021 | 17.0× | (55.60%) |
| FY2020 | 38.2× | 65.69% |
| FY2019 | 23.0× | (2.56%) |
| FY2018 | 23.6× | (5.02%) |
| FY2017 | 24.9× | 14.88% |
| FY2016 | 21.7× | 4.79% |
Quarterly
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 12.3× | (3.37%) |
| Mar 2026 | 12.7× | 0.96% |
| Dec 2025 | 12.6× | (3.83%) |
| Sep 2025 | 13.1× | (1.56%) |
| 42 more quarters | Free account |
Against its own ten years
Low 12.6×
High 38.2×
Ten-year median
20.7×
Current reading's percentile
9
Book value per share against peers
| Company | Book value per share |
|---|---|
| UTHR United Therapeutics Corporation compare | 150× |
| NBIX Neurocrine Biosciences, Inc. compare | 36.6× |
| ELAN Elanco Animal Health Incorporated compare | 13.2× |
| VTRS Viatris Inc. | 12.3× |
| ZTS Zoetis Inc. compare | 7.5× |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 6.7× |
| RDY Dr. Reddy's Laboratories Ltd compare | 5.2× |
| HIMS Hims & Hers Health, Inc. compare | 1.4× |
| HLN Haleon PLC Sponsored ADR compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on VTRS
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- The full statement